Will Drugs Someday Reverse CAD?

Three recent advances bring the possibility closer to reality.

Coronary artery disease (CAD) traditionally has been thought of as a progressive disease. Medical therapies have aimed at slowing its progression to reduce the risk of heart attack. A drug that could actually shrink plaque in the arteries was considered a dream. But clinical trials of three different approaches indicate that this dream may become a reality within our lifetime.
To continue reading this article or issue you must be a paid subscriber. Sign in

Subscribe to Heart Advisor

Get the next year of Heart Advisor for just $20. And access all of our online content - over 2,000 articles - free of charge.
Subscribe today and save 38%. It's like getting 5 months FREE!
Already Subscribed?
Click Here to Sign In | Forgot your password? | Activate Web Access